Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EBIT (2024 - 2025)

Historic EBIT for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$17.0 million.

  • Beta Bionics' EBIT fell 5526.1% to -$17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$68.6 million, marking a year-over-year change of. This contributed to the annual value of -$45.3 million for FY2024, which is 2622.32% down from last year.
  • Beta Bionics' EBIT amounted to -$17.0 million in Q3 2025, which was down 5526.1% from -$19.9 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' EBIT ranged from a high of -$9.5 million in Q1 2024 and a low of -$19.9 million during Q2 2025